Carbamoylcholine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Carbamoylcholine. Educational only — not medical advice.
Labeled uses
Intraocular use for obtaining miosis during surgery. In addition, MIOSTAT* (carbachol intraocular solution, USP) 0.01% reduces the intensity of IOP elevation in the first 24 hours after cataract surgery.
Source: FDA labeling via NIH DailyMed (set f28d7a56…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.